NCT04149990View on ClinicalTrials.gov

Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI

PHASE2TerminatedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

July 6, 2022

Study Completion Date

June 6, 2023

Conditions

Myocardial InfarctionDiastolic Dysfunction

Interventions

DRUG

Entresto Pill

NO other interventions

Trial Locations (2)

2100

Department of Cardiology, Rigshospitalet, Copenhagen

5000

Department of Cardiology, Odense Universityhospital, Odense

Sponsors

Collaborators (1)

Danish Heart Foundation

All Listed Sponsors

collaborator

Danish Heart Foundation

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

lead

Jacob Moller

OTHER